Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00321997
What this trial is testing

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 540
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Not applicableStudy completedNCT01666821
What this trial is testing

A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population

Who this might be right for
Geographic AtrophyWet Macular DegenerationRetinal Drusen
Shanghai University of Traditional Chinese Medicine 59
Not applicableStudy completedNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Testing effectiveness (Phase 2)Ended earlyNCT03452527
What this trial is testing

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationWet Macular Degeneration
Iconic Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT02022540
What this trial is testing

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration (AMD)
PanOptica, Inc. 50
Large-scale testing (Phase 3)Study completedNCT01782989
What this trial is testing

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Who this might be right for
Geographic Atrophy
Paul Yates, MD, PhD 286
Not applicableStudy completedNCT01840683
What this trial is testing

HELP Therapy for Dry AMD

Who this might be right for
Non-exudative (Dry) Age-related Macular Degeneration (AMD)
B.Braun Avitum AG 22
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableStudy completedNCT04138420
What this trial is testing

Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Federico II University 38
Not applicableStudy completedNCT04723160
What this trial is testing

Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph

Who this might be right for
Diabetic RetinopathyRetinal Vein OcclusionRetinal Artery Occlusion+10 more
Visionary Intelligence Ltd. 748
Not applicableStudy completedNCT03939195
What this trial is testing

OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)

Who this might be right for
Macular Degeneration Exudative Eye LeftMacular Degeneration Exudative Eye Right
Centre Hospitalier Intercommunal Creteil 130
Not applicableLooking for participantsNCT07434713
What this trial is testing

EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study Investigating the Fluid Dynamics During Early Response to Aflibercept 8mg in Patients With Exudative Age-related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration (AMD)
Insel Gruppe AG, University Hospital Bern 50
Testing effectiveness (Phase 2)Study completedNCT03861234
What this trial is testing

Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 43
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Not applicableStudy completedNCT01526070
What this trial is testing

Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Stanford University 142
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Next Page